Related by context. All words. (Click for frequent words.) 77 Acute Myocardial Infarction 77 Thrombolysis 74 Acute Coronary Syndromes 74 Unfractionated Heparin 74 Stenting 73 Carotid Stenting 73 Acute Ischemic Stroke 72 Guideline Update 72 Patients Undergoing 72 Venous Thromboembolism 72 Coronary Artery Bypass Graft 71 Abciximab 71 Left Ventricular 71 ST Segment Elevation 71 Acute Coronary Syndrome 70 Myocardial Infarction 70 Prospective Randomized 70 Patient Outcomes 70 primary percutaneous coronary 70 Diabetic Patients 70 Anticoagulation 69 Heart Failure Patients 69 Angiographic 69 Restenosis 69 Patients Treated 69 Randomized Evaluation 69 Infarction 69 Pivotal Trial 69 Myocardial Infarction Study 69 Elderly Patients 69 Carotid Revascularization Endarterectomy vs. 69 undergoing Percutaneous Coronary 69 Myocardial Ischemia 69 Cardiovascular Outcomes 69 Drug Eluting Stents 69 fibrinolytic therapy 68 ST Elevation Myocardial 68 Radical Prostatectomy 68 Carotid Endarterectomy 68 Monotherapy 68 Renal Cell Carcinoma 68 Patients Treated With 68 MADIT II 68 Recurrent Stroke 68 Coronary Angiography 68 coronary intervention 68 Unstable Angina 68 Aortic Stenosis 68 Rheumatoid Arthritis Patients 68 coronary revascularization 68 Ischemic Stroke 68 Cardiogenic Shock 68 patients undergoing percutaneous 68 Vertebroplasty 68 Adjuvant Chemotherapy 68 Randomized Controlled Trial 68 Bare Metal Stent 68 Platelet Inhibition 68 Stent Thrombosis 68 Enoxaparin 68 Pegylated Liposomal Doxorubicin 68 Clinical Trial Evaluating 68 thrombolytic therapy 68 Adjuvant Therapy 67 Tumor Response 67 Bare Metal Stents 67 Nesiritide 67 Severe Sepsis 67 Randomized Clinical Trial 67 STRIDE PD 67 Percutaneous Coronary Interventions 67 Survival Benefit 67 unfractionated heparin UFH 67 Dual Antiplatelet Therapy 67 Study Evaluating 67 Adjunctive 67 Newly Diagnosed Multiple Myeloma 67 Patency 67 Metastatic Prostate Cancer 67 Radiofrequency Ablation 67 Cardiac Resynchronization Therapy 67 Acute Decompensated Heart Failure 67 Renal Function 67 Aortic Dissection 67 Ranolazine 66 Stable Angina 66 Fondaparinux 66 Statin Therapy 66 Improves Survival 66 acute STEMI 66 Relapsing Multiple Sclerosis 66 Implantable Cardioverter Defibrillator 66 Postmenopausal Women 66 Intracranial Aneurysms 66 Coronary Revascularization 66 Refractory Angina 66 Investigational Drug 66 Aortic Valve 66 Localized Prostate Cancer 66 periprocedural 66 Clopidogrel 66 Aggressive Drug Evaluation 66 Cardiovascular Events 66 Cardiac Resynchronization 66 Colorectal Cancer Patients 66 Long Term Efficacy 66 Oral Fingolimod 66 Infarct 66 Renal Artery 66 Uterine Fibroid Embolization 66 Carotid 66 Improve Survival 66 percutaneous coronary intervention 66 Catheter Ablation 66 Risk Stratification 66 Hormone Refractory Prostate Cancer 66 Randomized Study 66 repeat revascularization 66 Left Ventricular Dysfunction 66 Acute Heart Failure 66 Pooled Analysis 66 clopidogrel pretreatment 66 carotid artery stenting 66 elective PCI 66 Randomized Controlled Trials 66 revascularisation 66 Chronic Heart Failure 66 tenecteplase 66 Bivalirudin 66 Decompensated Heart Failure 66 Patients Receiving 65 Clinical Outcome 65 Castration Resistant Prostate Cancer 65 percutaneous intervention 65 Pulmonary Arterial Hypertension 65 Neoadjuvant 65 Metastatic Renal Cell Carcinoma 65 Improve Outcomes 65 Coronary Artery Bypass Grafting 65 Well Tolerated 65 ExTRACT TIMI 65 Prospective Multicenter 65 Chemoradiation 65 Aggressive Reduction 65 Septic Shock 65 Improves Outcomes 65 Stent Restenosis 65 Diabetic Nephropathy 65 ARIXTRA 65 Phase III Clinical Trial 65 Ischemic 65 Phase 2b Study 65 reinfarction 65 Val HeFT 65 Neoadjuvant Chemotherapy 65 GP IIb IIIa inhibitors 65 Improved Survival 65 Follicular Lymphoma 65 Advanced Renal Cell 65 Occlusive Disease 65 CT Angiography 65 NSTE ACS 65 Obese Patients 65 Events MACE 65 Renal Impairment 65 stable angina 65 Mitral Regurgitation 65 Thromboembolism 65 Clinical Efficacy 65 Combination Treatment 65 Is Well Tolerated 65 NAVISTAR R 65 acute myocardial infarction AMI 65 EVEREST II 65 Gastric Cancer 65 Intracranial 65 Hip Fracture 65 ATACAND 65 Randomized Phase II 65 Controlled Trial 65 Prolongs Survival 65 Hypotension 65 Randomized Double Blind 65 Pivotal Clinical Trial 65 sirolimus eluting stents 65 Reduces Mortality 65 Intracerebral Hemorrhage 65 Accelerated Partial Breast Irradiation 65 Endarterectomy 65 paclitaxel eluting stents 65 Breaking Clinical Trials 64 Complete Remission 64 Total Knee Arthroplasty 64 Stereotactic Body Radiation Therapy 64 unstable angina UA 64 STEMI patients 64 Long Term Outcomes 64 Carotid Artery Stenting 64 Echocardiographic 64 Clinical Trial Results 64 Aortic Valve Replacement 64 invasive aspergillosis 64 Relapsing Remitting Multiple Sclerosis 64 Solid Tumors 64 Prostate Cancer Patients 64 Myelodysplastic Syndromes 64 Edge STudy 64 Statistically Significant 64 Relapsed Multiple Myeloma 64 Catheterization 64 percutaneous transluminal coronary angioplasty 64 Advanced Melanoma 64 Less Invasive 64 Metastatic Colorectal Cancer 64 Minimally Invasive Treatment 64 Treatment Regimen 64 Pivotal Phase III 64 Androgen Deprivation Therapy 64 Aneurysm Repair 64 Prospective Randomized Trial 64 tirofiban 64 Acute Myocardial 64 Meets Primary Endpoint 64 aldosterone antagonists 64 Bone Mineral Density 64 Post Operative 64 Induction Chemotherapy 64 Lenalidomide 64 Phase III Trial 64 endarterectomy 64 Vertebral Compression Fractures 64 Appears Safe 64 Autologous Stem Cell Transplantation 64 colorectal liver metastases 64 XIENCE V PROMUS Stent 64 WallFlex Biliary RX 64 Pemetrexed 64 Overactive Bladder 64 IIIa inhibitor 64 Hemodialysis Patients 64 Antitumor Activity 64 CABG Surgery 64 thrombus aspiration 64 Versus Placebo 64 carotid endarterectomy 64 Stenting Trial CREST 64 Cholesterol Levels SPARCL 64 Unresectable 64 Lung Cancer Trial 64 Coronary Artery 64 Surgical Procedures 64 Doxil ® 64 Acute Stroke 64 Cutaneous T 64 angioplasty stenting 64 liver resection 64 Ejection Fraction 64 Breast Density 64 Resection 64 AA Amyloidosis 64 Drug Eluting Stent 64 Dose Escalation 64 Peginterferon 64 fondaparinux 64 Transcatheter 64 Dabigatran 64 Antiplatelet Therapy 64 EURIDIS 64 Thrombus 64 Chronic Hepatitis C 64 Ventricular Arrhythmias 63 ENDEAVOR IV 63 Adjuvant Treatment 63 Sentinel Lymph Node Biopsy 63 Knee Osteoarthritis 63 Reperfusion 63 fibrinolysis 63 Ventricular 63 Intravitreal 63 DAPT 63 Antihypertensive 63 Cardiotoxicity 63 Randomized Trials 63 Radiation Dose 63 Anticoagulants 63 postprocedure 63 transurethral resection 63 Advanced Colorectal Cancer 63 Invasive Breast Cancer 63 Pelvic Organ Prolapse 63 Benign Prostatic Hyperplasia 63 Resistant Hypertension 63 Anticoagulant 63 Embolization 63 RE LY 63 Breast Cancer Recurrence 63 Percutaneous coronary intervention 63 Clostridium difficile Infection 63 Critically Ill Patients 63 Balloon Angioplasty 63 Coronary Syndromes 63 Coronary Artery Bypass Surgery 63 Chronic Renal Failure 63 Stent Implantation 63 Inhaled Nitric Oxide 63 eptifibatide 63 antithrombotic therapy 63 Metastatic Melanoma 63 Tiotropium 63 FOLFOX6 63 Valvular 63 ischemic cardiomyopathy 63 Venous Thrombosis 63 Fracture Risk 63 Percutaneous Transluminal Coronary Angioplasty 63 Prostate Cancer Treatment 63 Severe Asthma 63 Outpatient Setting 63 Implantable Cardioverter Defibrillators 63 ACUITY trial 63 carotid endarterectomy CEA 63 diagnostic angiography 63 drug eluting stent implantation 63 Lung Cancer Patients 63 Coronary Stent 63 Randomised Trial 63 CLARITY TIMI 63 Meta Analysis 63 Coronary artery bypass grafting 63 FASLODEX 63 Cardiac Arrest Patients 63 Clinical Evaluation 63 TRITON TIMI 63 Drug Eluting 63 Intra Arterial 63 Soft Tissue Sarcoma 63 CARE HF 63 Preclinical Data 63 Chronic Sinusitis 63 Complicated Skin 63 Plaque Psoriasis 63 Myocardial 63 Pivotal Phase 63 See CLINICAL PHARMACOLOGY 63 Randomized Double Blind Placebo 63 DES implantation 63 underwent CABG 63 Glycemic Control 63 antiarrhythmic drug 63 stage IIIb IV 63 TAXUS Liberte Long 63 Prostatectomy 63 Anthracycline 63 Nebulized 63 failure ADHF 63 Tolerability 63 Fluorouracil 63 revascularizations 63 Heart Failure Trial 63 OPCAB 63 Taxus Stent 63 undergoing coronary angiography 63 Subgroup Analysis 63 Clinical Outcomes Utilizing Revascularization 63 Liver Metastases 63 Peripheral Arterial 63 Ventricular Tachycardia 62 rFVIIa 62 transcatheter aortic valve implantation 62 Bevacizumab 62 Multicenter 62 Valvular Heart Disease 62 binary restenosis 62 everolimus eluting stents 62 Myeloma Patients 62 Hospitalized Patients 62 Sustained Efficacy 62 VTE prophylaxis 62 Randomised 62 percutaneous coronary interventions 62 Prophylaxis 62 Natalizumab 62 TAXUS ATLAS 62 Surgical Treatment 62 Placebo Controlled Trial 62 Intracoronary 62 chemoradiation therapy 62 Zoledronic Acid 62 Embolic 62 ischemia driven 62 RE LY ® 62 First Patient Enrolled 62 carotid artery stenting CAS 62 Cryoablation 62 Afib 62 Secondary Hyperparathyroidism 62 FDG-PET/CT 62 Randomized Double blind 62 recombinant tissue plasminogen 62 Multiple Myeloma Patients 62 Stent Placement 62 coronary stenting 62 Insulin Therapy 62 Hormone Receptor Positive 62 prospective randomized controlled 62 Golimumab 62 thrombolysis 62 Diabetic Macular Edema 62 II Clinical Trial 62 Coronary CTA 62 JAK Inhibitor 62 Percutaneous Tibial Nerve Stimulation 62 Previously Treated 62 Phase IIb Trial 62 Increased Mortality 62 reperfusion therapy 62 non valvular atrial 62 Induction Therapy 62 symptomatic carotid stenosis 62 Treatment Resistant 62 Non Responders 62 Prognostic Significance 62 Demonstrate Significant 62 Liver Failure 62 Valve Replacement 62 asymptomatic carotid stenosis 62 BRIM2 62 HSCT 62 Total Hip Replacement 62 thromboprophylaxis 62 Low Dose 62 Depressive Symptoms 62 ACE Inhibitors 62 Newly Diagnosed Breast Cancer 62 CYPHER R Sirolimus Eluting 62 Randomized Clinical Trials 62 Phase IIb Clinical Trial 62 NATRECOR ® 62 Revascularization 62 Prevent Stroke 62 Diastolic Heart Failure 62 Study Showed 62 Investigational Agent 62 NMIBC 62 Thrombectomy 62 Intravesical 62 cardiac resynchronisation therapy 62 multivessel disease 62 Phase 2b Clinical Trial 62 Insulin Glargine 62 Adverse Event 62 fosbretabulin 62 Postmenopausal Osteoporosis 62 Total Hip Arthroplasty 62 Multicenter Study 62 achieved CCyR 62 Acute MI 62 Hemolysis 62 Controlled Study 62 TAXUS Stent 62 Demonstrates Sustained 62 antiplatelet medications 62 SYNTAX 62 unstable angina pectoris 62 ST elevation myocardial 62 Diffuse Large B 62 Malignant Melanoma 62 Long Lesion 62 multicentre randomized 62 β blockers 62 Rosuvastatin 62 Sudden Cardiac Death 62 NYHA Class II 62 Pegylated Interferon 62 MACCE 62 PRoFESS 62 neoadjuvant therapy 62 Disease Progression 62 Robotic Assisted 62 Valsartan 62 Metabolic Efficiency 62 Embolic Protection 62 Treatment Naive Patients 62 Peginterferon Alfa 2a 62 Kidney Transplant Patients 62 Carotid Artery 62 Orthostatic Hypotension 62 Completes Enrollment 62 Endovascular Repair 62 UA NSTEMI 62 alteplase 62 argatroban 62 ischemic complications 62 Free Survival PFS 62 Diabetic Foot Ulcer 62 aspirin heparin 62 ACE Inhibitor 62 Ischaemic 62 Treating Chronic 62 Refractory Hodgkin Lymphoma 62 Immunosuppression 62 Breast Cancer Treatment 62 coronary angiography 62 NATRECOR R 62 echocardiographic 62 Newly Diagnosed 62 Advanced Prostate Cancer 62 recurrent glioblastoma multiforme 62 Antiviral Activity 62 Hsp# Inhibitor 62 Malignant Glioma 62 Sirolimus Eluting Stent 61 Demonstrated Significant 61 Heart Transplant Recipients 61 Artery Disease 61 Sustained Virologic Response 61 zotarolimus eluting stent 61 TAVI 61 refractory ischemia 61 riociguat 61 curative resection 61 Anti Tumor Activity 61 Nymox NX 61 Significantly Reduced 61 nicardipine 61 HCV SPRINT 61 relapsed refractory multiple myeloma 61 Total Knee Replacement 61 Cyclophosphamide 61 sunitinib Sutent 61 catheter occlusion 61 Phase III Pivotal Trial 61 COPERNICUS 61 Predict Risk 61 Reduced Risk 61 Multicenter Trial 61 Endovascular Treatment 61 Esophageal 61 Transcatheter Aortic Valve Implantation 61 Bronchial Thermoplasty 61 cilostazol 61 Treated Patients 61 ICD implantation 61 Lung Injury 61 Deep Venous Thrombosis 61 stage IIIB 61 Angiogram 61 glycoprotein IIb IIIa inhibitors 61 Cell Lymphoma 61 Lipid Lowering Treatment 61 venous thromboembolic disease 61 Preterm Delivery 61 Randomized Phase III 61 Double Blind Placebo 61 arteriography 61 Physical Function 61 Hepatocellular Carcinoma 61 CALGB # [002] 61 Node Positive 61 occlusive disease 61 Cost Effectiveness 61 dual endothelin receptor antagonist 61 Pediatric Patients 61 multicenter prospective 61 serum phosphorous 61 oral antidiabetic medication 61 infarction STEMI 61 Coronary Artery Disease 61 Decitabine 61 R# #mg BID 61 Advanced Ovarian Cancer 61 Randomized Phase 61 Platinol ® 61 Breast conserving 61 stent implantation 61 5 Fluorouracil 61 Cholesterol Lowering Drug 61 abciximab 61 SYNTAX trial 61 Boosts Survival 61 Investigational Treatment 61 oral rivaroxaban 61 Squamous Cell Carcinoma 61 Renal Tumors 61 Anti Bacterial Envelope 61 Cypher Sirolimus 61 Enhanced External Counterpulsation 61 Hernia Repair 61 Glatiramer Acetate 61 Xelox 61 Ultrasound Guided 61 Reperfusion Injury 61 Diabetic Neuropathic Pain 61 CHAMPION PCI 61 Demonstrates Significant 61 Demonstrates Positive 61 Vascugel ® 61 Lung Function 61 Endovascular Valve Edge 61 Heart Failure 61 ipsilateral stroke 61 Circulatory Support 61 Gemcitabine 61 Chronic Lymphocytic Leukemia 61 First Patient Treated 61 Placebo Controlled Study 61 Randomised Controlled Trial 61 Adjunctive Therapy 61 randomized multicenter trial 61 certolizumab 61 Acute Migraine 61 Interventional Procedures 61 Brain Metastases 61 Combination Therapy 61 undergoing coronary artery 61 pulmonary artery catheterization 61 Molecular Weight Heparin 61 acute coronary syndromes 61 Systemic Sclerosis 61 Hyperlipidemia 61 Chronic Constipation 61 Hypertensive Patients 61 #mg BID [001] 61 Fractional Flow Reserve 61 Randomized Placebo Controlled Trial 61 Kidney Function 61 prospective multicenter study 61 aspirin clopidogrel 61 bivalirudin alone 61 STEMI undergoing 61 antiplatelet therapy 61 PROMUS TM 61 Eluting Stent 61 infarction NSTEMI 61 FIRMAGON 61 follicular lymphoma FL 61 patients undergoing CABG 61 Sirolimus eluting Coronary Stent 61 Anterior Cruciate Ligament Reconstruction 61 nonrandomized 61 Thrombus Aspiration 61 Congestive Heart Failure 61 PEGINTRON TM 61 Mycophenolate Mofetil 61 multicenter randomized controlled 61 Sapacitabine 61 Recurrent Prostate Cancer 61 Blood Pressure Lowering 61 Osteoarthritis Patients 61 Statistical Significance 61 Fungal Infections 61 Rivaroxaban 61 DEFER 61 undergoing percutaneous coronary 61 Cypher Stent 61 Infliximab 61 Prostate Biopsy 61 acute coronary syndrome 61 Bypass Surgery 61 transthoracic 61 Microalbuminuria 61 chemoradiotherapy 61 Cognitive Impairment 61 ARCOXIA 61 Bloodstream Infections 61 Slow Progression 61 Cardiopulmonary bypass 61 Antidepressant Treatment 61 Chronic Myeloid Leukemia 60 Atrial 60 postoperative atrial fibrillation 60 Ablation 60 Bipolar Depression 60 Granted Orphan Drug 60 Cardiovascular Risk 60 medically inoperable 60 underwent resection 60 Postoperative 60 PROMUS R 60 metastatic malignant 60 INTEGRILIN R 60 beta blocker therapy 60 metastatic renal cell carcinoma 60 Ambulatory Blood Pressure 60 Mortality Risk 60 perioperatively 60 Topline Results 60 carotid stenting 60 Phase 2a Clinical Trial 60 Non inferiority 60 Cardiopulmonary Bypass 60 Peripheral Vascular Disease 60 NDA Submission 60 allogeneic stem cell 60 eplerenone 60 CIMZIA ™ 60 Hormone Therapy 60 Patients Enrolled 60 colesevelam HCl 60 parathyroidectomy 60 Acute Myocardial Infarction AMI 60 Blood Pressure Reduction 60 Pancreatic Adenocarcinoma 60 sirolimus eluting 60 Estrogen Therapy 60 Brain Aneurysms 60 Kidney Transplantation 60 Treating Heart Failure 60 Balloon Kyphoplasty 60 Catheter Associated 60 Feasibility Trial 60 Acute Coronary Syndromes ACS 60 noninvasive outpatient 60 Diuretic 60 percutaneous vertebroplasty 60 rt PA 60 CYPHER R Sirolimus eluting 60 EchoCRT 60 Endometrial Cancer 60 Capecitabine 60 Prophylactic Treatment 60 Beta Blocker 60 severe exacerbations 60 heparin induced thrombocytopenia 60 Randomized Comparison 60 ENDEAVOR III 60 IV NSCLC 60 pain palliation 60 recurrent DVT 60 perioperative complications 60 Nonsurgical 60 Relapsed 60 acute coronary syndromes ACS 60 Regimens 60 elective percutaneous coronary 60 Left Ventricular Hypertrophy 60 ribavirin RBV 60 left ventricular dysfunction 60 relapsed MM 60 Arch Intern Med 60 Thyroid Hormone 60 TURBT 60 Single Dose 60 ARIXTRA R 60 FOLFOX4 60 Randomized Controlled 60 Inflammatory Markers 60 landmark ATHENA trial 60 composite endpoint 60 Aromatase Inhibitors 60 Treatment Reduces 60 Anti Clotting Drug 60 NCT# ClinicalTrials.gov 60 randomized Phase IIb 60 TM Drug Eluting 60 lipid lowering drugs 60 surgical revascularization 60 TAXUS Express Stent 60 Naive Patients 60 Acute Pancreatitis 60 Embolic Protection Device 60 symptomatic VTE 60 lung resection 60 Bone Metastases 60 Cholinesterase Inhibitors 60 Urinary Incontinence 60 Ovarian Cancer Patients 60 Pharmacokinetic Study 60 Folfox 60 Clinical Outcomes 60 Pioglitazone 60 Sipuleucel T 60 Adult Stem Cell Therapy 60 Sirolimus Eluting 60 Cognitive Function 60 ILLUSTRATE 60 chemoembolization 60 DVT prophylaxis 60 Virtual Colonoscopy 60 Gene Variation 60 Bladder Cancer 60 Efficacious 60 Adenomas 60 candesartan cilexetil 60 AVERROES 60 LUMINATE 60 Implantable Defibrillator 60 GP IIb IIIa inhibitor 60 intravesical infusion therapy 60 oral anticoagulation 60 nonfatal myocardial infarction 60 Erlotinib 60 Cell Lung Cancer 60 NeuroStar TMS Therapy 60 cangrelor 60 revascularization procedures 60 CIMZIA TM certolizumab pegol 60 Treatment Experienced 60 MULTAQ 60 ACC AHA 60 coronary interventions 60 Non Inferiority 60 Breast Cancer Patients 60 Oral Anticoagulants 60 Breast Carcinoma 60 duplex ultrasonography 60 Mitral Valve Repair 60 anticoagulated 60 deep venous thromboses 60 thromboembolic 60 MR Angiography 60 J Am Coll 60 CUSTOM III 60 FDA Approvals 60 NSABP B 60 adjuvant radiotherapy 60 MTWA testing 60 Antiplatelet 60 angiotensin converting enzyme inhibitors 60 Antiangiogenic 60 Capsule Endoscopy 60 Traficet EN 60 RENAL 60 Minimally Invasive Procedure 60 recurrent ischemia 60 neoadjuvant 60 renal artery stenosis 60 Prognostic Value 60 USpella 60 Acute Coronary 60 Recurrent Breast Cancer 60 Contrast Enhanced 60 sorafenib Nexavar 60 ENDEAVOR II 60 Medication Adherence 60 Improved Outcomes 60 Novel Antibiotic 60 symptomatic intracranial 60 Spinal Manipulation 60 Neovascular AMD 60 Intravascular 60 tumor lysis syndrome 60 Capsules CII 60 HCV Genotype 60 Celecoxib APC trial 60 STENT 60 Phase III Trials 60 thromboembolic events 60 Myelodysplastic Syndrome 60 mycophenolate mofetil 60 BARI 2D 60 Heparin Bioactive Surface 60 adjuvant radiation 60 stable angina pectoris 60 Peripheral Artery Disease 60 Anti TNF 60 MADIT 60 Laryngeal Cancer 60 Dialysis Patients 60 Treat Heart Failure 60 PICSO ® 60 cTnI 60 Fulvestrant 60 myocardial infarction stroke 60 XIENCE V demonstrated 60 concurrent chemoradiation 60 QTc prolongation 60 CHARM Added 60 Prostate Surgery 60 RE MODEL 60 Spinal Fractures 60 Hepatitis C Virus 60 Diabetic Neuropathy 60 Candesartan 60 Significantly Improved 60 Breast Cancers 60 Neuroendocrine Tumors 60 HER2 Positive Breast Cancer 60 cytoreductive surgery 60 Genes Predict 60 #F FDG PET 60 SCD HeFT 60 antiplatelet drugs 60 recurrent GBM 60 dose escalation phase 60 LV dysfunction 60 Sirolimus eluting 60 Prostate Cancer Recurrence 60 Cystectomy 60 nab paclitaxel 60 Dialysis Outcomes 60 Carcinoma 60 Phase III Pivotal 60 coronary revascularisation 60 Metastatic Pancreatic Cancer 60 Desvenlafaxine Succinate 60 Cilostazol 60 R lenalidomide 60 SilverHawk Plaque Excision System 60 ARB telmisartan 60 morphometric vertebral fractures 60 Shows Efficacy 60 randomized controlled multicenter 60 MEND CABG 60 Previously Untreated 60 Intervention Effectiveness 60 Newly Diagnosed Patients 60 Nilotinib 60 Interferon Alfa 60 silent ischemia 60 mildly symptomatic 60 HCV Protease Inhibitor 60 REALITY Trial 60 saphenous vein graft 60 iodixanol 60 Combo Therapy 60 percutaneous nephrolithotomy 60 Anticancer Activity 60 atypical Hemolytic Uremic Syndrome 60 Dose Ranging Study 60 blinded randomized placebo controlled 59 Tipranavir 59 Beta Blockers 59 Atherosclerotic 59 Diabetic Kidney Disease 59 ACTEMRA TM 59 Endometrial 59 Enzastaurin 59 Adenoma Prevention 59 Colorectal Screening 59 Implantable Cardioverter Defibrillator ICD 59 Systolic Blood Pressure 59 LMWH 59 Levels Linked 59 Colorectal Cancer Screening 59 Demonstrates Efficacy 59 Stenting Trial 59 Pharmacokinetics PK 59 PLX STROKE targeting 59 Ozarelix 59 neoadjuvant chemotherapy 59 Hyperkalemia 59 revascularization procedure 59 ZOLINZA 59 dose atorvastatin 59 Hip Fractures 59 phase IIIb 59 prospective multicentre 59 Relapsed Refractory Multiple Myeloma 59 Therapy Reduces 59 Coronary angiography 59 colon resection 59 TAXUS TM 59 VAPRISOL 59 Drug Coated Stent 59 Pivotal Study 59 standard chemotherapy regimen 59 Pivotal Trials 59 descending thoracic 59 Ischemia 59 Stenosis 59 BENICAR 59 Survival Rates 59 dalteparin 59 everolimus eluting stent 59 prospectively stratified 59 Pralatrexate 59 Corticosteroid 59 carotid angioplasty 59 Initiate Phase 59 Epoetin Alfa 59 Critical Limb Ischemia 59 fallopian tube cancers 59 atherothrombotic events 59 hepatic metastases 59 BR.# 59 Orally Active 59 Phase Ib Clinical Trial 59 prostate TURP 59 nonfatal myocardial infarction MI 59 undergo percutaneous coronary 59 functional mitral regurgitation 59 Thiazolidinediones 59 Osteoporosis Drugs 59 Phase IIa Clinical Trial 59 adalimumab Humira 59 MGd 59 glycoprotein IIb IIIa inhibitor 59 aldosterone antagonist 59 GORE TAG Device 59 CK MB 59 vWD 59 Relapsed Refractory 59 perioperative mortality 59 Spectrum Pharmaceuticals Announces 59 Sentinel Lymph Node 59 intravesical therapy 59 REMINDER ORLive Presents 59 Aliskiren